Quince Therapeutics, Inc. (QNCX) SEC Filings — 2025
10 SEC filings for Quince Therapeutics, Inc. (QNCX) in 2025.
Filings
- Quince Therapeutics' Q3 Loss Widens Amid Soaring R&D Costs — 10-Q · Nov 12, 2025
- Quince Therapeutics (fka Cortexyme) Files 8-K — 8-K · Oct 17, 2025
- Quince Therapeutics Enters Material Definitive Agreement — 8-K · Sep 26, 2025
- Quince Therapeutics Narrows Q2 Loss Amid R&D Cuts, Raises $10M — 10-Q · Aug 11, 2025
- Quince Therapeutics Files 8-K — 8-K · Jul 16, 2025
- Quince Therapeutics Files 8-K with Material Agreement — 8-K · Jun 13, 2025
- Quince Therapeutics Files 8-K on Security Holder Vote — 8-K · Jun 5, 2025
- Quince Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Quince Therapeutics Files DEF 14A on Executive Compensation — DEF 14A · Apr 23, 2025
- Quince Therapeutics Files 2024 10-K — 10-K · Mar 24, 2025